• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
SUN Zhuolin, LIU Jingwei, KUANG Changchun. Inhibitions and mechanisms of amygdalin in non-small cell lung cancer NCI-H1299 cell line invasion in vitro[J]. Journal of China Pharmaceutical University, 2016, 47(4): 479-482. DOI: 10.11665/j.issn.1000-5048.20160415
Citation: SUN Zhuolin, LIU Jingwei, KUANG Changchun. Inhibitions and mechanisms of amygdalin in non-small cell lung cancer NCI-H1299 cell line invasion in vitro[J]. Journal of China Pharmaceutical University, 2016, 47(4): 479-482. DOI: 10.11665/j.issn.1000-5048.20160415

Inhibitions and mechanisms of amygdalin in non-small cell lung cancer NCI-H1299 cell line invasion in vitro

More Information
  • The aim of this study was to investigate the effects and mechanisms of a nature product, amygdalin, in non-small cell lung cancer NCI-H1299 cell line invasion and migration in vitro. NCI-H1299(H1299)cells were treated with amygdalin. MTS assay was employed to determine cell proliferation, transwell chamber and wound-healing assay were employed to determine invasion and migration in vitro, western blotting and RT-PCR assay were employed to determine the expression of integrin β1, integrin β4, integrin-linked kinase(ILK), focal adhesion kinase(FAK), p-FAK and β-catenin, and the phosphorylation of Akt and RICTOR. Results showed that in vitro proliferation of H1299 cells were inhibited significantly after treated with 0. 5 and 1 mg/mL amygdalin for 48 h. The invasion and migration potential was decreased. The protein and mRNA expression of MMP-2/9, integrin β1/4, ILK, FAK, β-catenin, the activity of MMP-2/9, the phosphorylation of FAK, Akt and RICTOR were all decreased significantly(all of P< 0. 05).
  • [1]
    Reck M,Popat S,Reinmuth N,et al.Metastatic non-small-cell lung cancer(NSCLC):ESMO clinical practice guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2014,25(Suppl 3):iii27-39.
    [2]
    Bolarinwa IF,Orfila C,Morgan MR.Amygdalin content of seeds,kernels and food products commercially-available in the UK[J].Food Chemistry,2014,152:133-139.
    [3]
    Makarevi 'c J,Rutz J,Juengel E,et al.Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2[J].PLoS One,2014,9(8):e105590.
    [4]
    Niu G,Ye T,Qin L,et al.Orphan nuclear receptor TR3/Nur77 improves wound healing by upregulating the expression of integrin β4[J].FASEB J,2015,29(1):131-140.
    [5]
    Matsubara D,Kishaba Y,Yoshimoto T,et al.Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer[J].Pathol Int,2014,64(11):560-568.
    [6]
    Song JL,Nigam P,Tektas SS,et al.MicroRNA regulation of Wnt signaling pathways in development and disease[J].Cell Signal,2015,27(7):1380-1391.
    [7]
    Sulzmaier FJ,Jean C,Schlaepfer DD.FAK in cancer:mechanistic findings and clinical applications[J].Nat Rev Cancer,2014,14(9):598-610.
    [8]
    Fumarola C,Bonelli MA,Petronini PG,et al.Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer[J].Biochem Pharmacol,2014,90(3):197-207.
    [9]
    Calderaro J,Rebouissou S,de Koning L,et al.PI3K/AKT pathway activation in bladder carcinogenesis[J].Int J Cancer,2014,134(8):1776-1784.
    [10]
    Liu Y,Wang TT,Chen L.Synthesis and antitumor activity of isosteviol derivatives[J].J China Pharm Univ(中国药科大学学报),2016,47(1):48-53.
  • Related Articles

    [1]SHAO Shishuai, DUAN Shukang, TIAN Hong, YAO Wenbing, GAO Xiangdong. Design and antitumor activity of programmed cell death ligand 1 epitope peptide vaccine[J]. Journal of China Pharmaceutical University, 2023, 54(2): 245-254. DOI: 10.11665/j.issn.1000-5048.2023022803
    [2]CHU Xuxin, BU Fanxue, YIN Tingjie, HUO Meirong. Antitumor strategies based on targeted modulation of tumor-associated macrophages[J]. Journal of China Pharmaceutical University, 2021, 52(3): 261-269. DOI: 10.11665/j.issn.1000-5048.20210301
    [3]WANG Tianshuai, YU Junjie, ZHANG Yan, ZENG Jinjin, CUI Jingxin. Advances in platinum-intercalators of DNA as antitumor agents[J]. Journal of China Pharmaceutical University, 2019, 50(5): 505-515. DOI: 10.11665/j.issn.1000-5048.20190501
    [4]HE Junjin, WANG Jiayi, HAO Jingchao, CHENG Haoran, XU Hanmei. Antitumor effect of peptide mPEG-SC20k-HM-3 and oxaliplatin combination against human hepatocellular carcinoma SMMC-7721 in nude mice[J]. Journal of China Pharmaceutical University, 2015, 46(4): 476-480. DOI: 10.11665/j.issn.1000-5048.20150415
    [5]CHENG Haibo, XU Bin, ZHANG Huibin, ZHOU Jinpei. Synthetic process of antitumor drug dacomitinib[J]. Journal of China Pharmaceutical University, 2014, 45(2): 165-169. DOI: 10.11665/j.issn.1000-5048.20140206
    [6]HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105
    [7]YANG Yong-fang, YAN Hai-qiang, DING Guo-fang, HUANG Fang-fang. Isolation and purification of an anticancer activity peptide from protein hydrolysate of Mytilus coruscus[J]. Journal of China Pharmaceutical University, 2011, 42(3): 272-275.
    [8]Research of anti-tumor peptide neutralizing antibodies activities[J]. Journal of China Pharmaceutical University, 2010, 41(2): 171-174.
    [9]Tumor microenvironment:A novel target for antitumor activity of polysaccharides[J]. Journal of China Pharmaceutical University, 2010, 41(1): 1-10.
    [10]Studies on the Antitumor Principles of Herba Artemisiae capillaris[J]. Journal of China Pharmaceutical University, 1992, (5): 283-286.

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return